Mesoblast Limited (ASX: MSB)
Australia
· Delayed Price · Currency is AUD
3.170
-0.180 (-5.37%)
Jan 3, 2025, 4:10 PM AEST
Mesoblast Employees
Mesoblast had 73 employees as of June 30, 2024. The number of employees decreased by 10 or -12.05% compared to the previous year.
Employees
73
Change (1Y)
-10
Growth (1Y)
-12.05%
Revenue / Employee
121.18K AUD
Profits / Employee
-1.81M AUD
Market Cap
3.62B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
CSL Limited | 32,698 |
Pro Medicus | 69 |
Cochlear | 5,097 |
Sonic Healthcare | 42,000 |
Telix Pharmaceuticals | 234 |
Ramsay Health Care | 90,000 |
Ansell | 15,000 |
Regis Healthcare | 11,000 |
Mesoblast News
- 5 days ago - Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday - Benzinga
- 12 days ago - This Mesoblast Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday - Benzinga
- 16 days ago - What's Going On With Mesoblast Shares Thursday? - Benzinga
- 16 days ago - Mesoblast Finally Gets Its Approval In GVHD: Where Now? - Seeking Alpha
- 16 days ago - Mesoblast's Cell Therapy Treatment For Graft Versus Host Disease Gets FDA Approval, Stock Surges - Benzinga
- 16 days ago - Mesoblast's Cell Therapy Treatment For Graft Versus Host Disease Gets FDA Approval, Stock Surges - Benzinga
- 16 days ago - Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga
- 16 days ago - Mesoblast shares rocket on FDA approval, but CEO says risks remain - The Australian Financial Review